9-132275229-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_015046.7(SETX):c.7100+27A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.138 in 1,607,116 control chromosomes in the GnomAD database, including 19,889 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.17 ( 2655 hom., cov: 32)
Exomes 𝑓: 0.13 ( 17234 hom. )
Consequence
SETX
NM_015046.7 intron
NM_015046.7 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.583
Publications
6 publications found
Genes affected
SETX (HGNC:445): (senataxin) This gene encodes a protein named for its homology to the Sen1p protein of fungi which has RNA helicase activity encoded by a domain at the C-terminal end of the protein. The protein encoded by this gene contains a DNA/RNA helicase domain at its C-terminal end which suggests that it may be involved in both DNA and RNA processing. Mutations in this gene have been associated with ataxia-ocular apraxia-2 (AOA2) and an autosomal dominant form of juvenile amyotrophic lateral sclerosis (ALS4). [provided by RefSeq, Jul 2008]
SETX Gene-Disease associations (from GenCC):
- amyotrophic lateral sclerosis type 4Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
- distal hereditary motor neuropathyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 9-132275229-T-C is Benign according to our data. Variant chr9-132275229-T-C is described in ClinVar as Benign. ClinVar VariationId is 260516.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.413 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SETX | NM_015046.7 | c.7100+27A>G | intron_variant | Intron 23 of 25 | ENST00000224140.6 | NP_055861.3 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SETX | ENST00000224140.6 | c.7100+27A>G | intron_variant | Intron 23 of 25 | 1 | NM_015046.7 | ENSP00000224140.5 | |||
| SETX | ENST00000464133.1 | n.325A>G | non_coding_transcript_exon_variant | Exon 3 of 3 | 2 | |||||
| SETX | ENST00000436441.5 | c.1826+27A>G | intron_variant | Intron 13 of 16 | 5 | ENSP00000409143.1 | ||||
| SETX | ENST00000477049.1 | n.127+27A>G | intron_variant | Intron 1 of 4 | 3 |
Frequencies
GnomAD3 genomes AF: 0.169 AC: 25615AN: 151998Hom.: 2654 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
25615
AN:
151998
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.171 AC: 42922AN: 250898 AF XY: 0.173 show subpopulations
GnomAD2 exomes
AF:
AC:
42922
AN:
250898
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.134 AC: 195373AN: 1455000Hom.: 17234 Cov.: 29 AF XY: 0.138 AC XY: 100111AN XY: 724314 show subpopulations
GnomAD4 exome
AF:
AC:
195373
AN:
1455000
Hom.:
Cov.:
29
AF XY:
AC XY:
100111
AN XY:
724314
show subpopulations
African (AFR)
AF:
AC:
8447
AN:
33310
American (AMR)
AF:
AC:
6402
AN:
44706
Ashkenazi Jewish (ASJ)
AF:
AC:
4874
AN:
26052
East Asian (EAS)
AF:
AC:
18115
AN:
39614
South Asian (SAS)
AF:
AC:
22855
AN:
86062
European-Finnish (FIN)
AF:
AC:
6326
AN:
53020
Middle Eastern (MID)
AF:
AC:
1522
AN:
5746
European-Non Finnish (NFE)
AF:
AC:
117001
AN:
1106390
Other (OTH)
AF:
AC:
9831
AN:
60100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
7913
15826
23739
31652
39565
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
4660
9320
13980
18640
23300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.169 AC: 25643AN: 152116Hom.: 2655 Cov.: 32 AF XY: 0.173 AC XY: 12850AN XY: 74356 show subpopulations
GnomAD4 genome
AF:
AC:
25643
AN:
152116
Hom.:
Cov.:
32
AF XY:
AC XY:
12850
AN XY:
74356
show subpopulations
African (AFR)
AF:
AC:
10065
AN:
41480
American (AMR)
AF:
AC:
2153
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
AC:
711
AN:
3470
East Asian (EAS)
AF:
AC:
2207
AN:
5164
South Asian (SAS)
AF:
AC:
1357
AN:
4806
European-Finnish (FIN)
AF:
AC:
1226
AN:
10596
Middle Eastern (MID)
AF:
AC:
71
AN:
294
European-Non Finnish (NFE)
AF:
AC:
7424
AN:
68000
Other (OTH)
AF:
AC:
347
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1058
2116
3173
4231
5289
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
278
556
834
1112
1390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1208
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Aug 10, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Amyotrophic lateral sclerosis type 4 Benign:1
Feb 08, 2023
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 Benign:1
Feb 08, 2023
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.